Company intelligence / Profile preview

Bsafe Biotech

Sao Paulo, Sao Paulo, Brazilbsafebiotech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Developing novel biopesticides using RNA interference and microbial technologies to target agricultural pests. Focuses on safety, biodiversity preservation, and resistance management. No clinical results reported as it is not a clinical-stage company.

Therapeutic areas: Other
Modalities: RNA therapyMicrobial therapy
Industry: Agriculture & AgTech

Partnerships

StartLife (investor)

Beyond the preview

Go deeper on Bsafe Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bsafe Biotech.

Explore the full profile